Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

W-Z Biotech LLC
Profile last edited on: 1/17/2024      CAGE: 5SDY5      UEI: RK1ZDCXE3LJ7

Business Identifier: Novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy
Year Founded
2009
First Award
2011
Latest Award
2021
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1224 Raeford Lane
Lexington, KY 40513
   (859) 494-4134
   dwang.tx@gmail.com
   N/A
Location: Single
Congr. District: 06
County: Fayette

Public Profile

Despite two increments of funding for the firm's Phase II project initiated in 2016, Google indicates the firm as being permanently closed. The firm had been developing a percutaneous double lumen cannula (DLC) for cavopulmonary assistance

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
2
Conversion Rate
40.00%
Phase I Dollars
$929,910
Phase II Dollars
$2,497,688
Total Awarded
$3,427,598

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $225,000
Project Title: Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support
2019 2 NIH $1,646,010
Project Title: Development of Transapical to Aorta Double Lumen Cannula for a Neonate LVAD
2018 1 NIH $224,991
Project Title: Development of a Percutaneous Pulmonary Artery Drainage Device to Unload LV During VA Ecmo Support for Severe Cardiogenic Shock
2017 2 NIH $1,175,843
Project Title: Development of Percutaneous DLC for Total Cavo-Pulmonary Assistance
2012 1 NIH $155,754
Project Title: Development of Double Lumen Cannula for Percutaneous Right Heart Support

Key People / Management

  Dongfang Wang -- President, Co-Founder

  Bill Sidor

  Stephen R Topaz

  Jay Zwischenberger -- Co-Founder

Company News

There are no news available.